These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23958238)

  • 1. Interpretation of HLA single antigen bead assays.
    Ellis TM
    Transplant Rev (Orlando); 2013 Oct; 27(4):108-11. PubMed ID: 23958238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
    Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-specific antibody distribution in renal transplant waiting list patients: utility of antigen frequency data in the definition of HLA-reactive epitopes.
    Lowe D; Jones J; Middleton D
    Clin Transpl; 2013; ():433-40. PubMed ID: 25095539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
    Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
    Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Road to HLA Antibody Evaluation: Do Not Rely on MFI.
    Sullivan HC; Liwski RS; Bray RA; Gebel HM
    Am J Transplant; 2017 Jun; 17(6):1455-1461. PubMed ID: 28199773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation.
    Goldsmith P; Lowe D; Wong C; Howse M; Ridgway D; Hammad A; Mehra S; Christmas S; Gebel H; Bray R; Jones A
    Transpl Immunol; 2020 Oct; 62():101310. PubMed ID: 32574596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid phase assays for HLA antibody detection in clinical transplantation.
    Tait BD
    Curr Opin Immunol; 2009 Oct; 21(5):573-7. PubMed ID: 19765965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
    Greenshields A; Bray RA; Gebel HM; Liwski RS
    Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients.
    Süsal C; Roelen DL; Fischer G; Campos EF; Gerbase-DeLima M; Hönger G; Schaub S; Lachmann N; Martorell J; Claas F
    Tissue Antigens; 2013 Aug; 82(2):83-92. PubMed ID: 23718733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lights and shadows of anti-HLA antibodies detected by solid-phase assay.
    Picascia A; Sabia C; Grimaldi V; Montesano ML; Sommese L; Schiano C; Napoli C
    Immunol Lett; 2014 Nov; 162(1 Pt A):181-7. PubMed ID: 25171913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Becoming a chef in the human leukocyte antigen kitchen: interpretation and modification of human leukocyte antigen-antibody assays.
    Liwski RS; Greenshields AL; Bray RA; Gebel HM
    Curr Opin Organ Transplant; 2017 Aug; 22(4):407-414. PubMed ID: 28509678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.